These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32122838)

  • 21. Co-delivery of doxorubicin, docosahexaenoic acid, and α-tocopherol succinate by nanostructured lipid carriers has a synergistic effect to enhance antitumor activity and reduce toxicity.
    Lages EB; Fernandes RS; Silva JO; de Souza ÂM; Cassali GD; de Barros ALB; Miranda Ferreira LA
    Biomed Pharmacother; 2020 Dec; 132():110876. PubMed ID: 33113428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell penetrating peptides functionalized gambogic acid-nanostructured lipid carrier for cancer treatment.
    Huang R; Li J; Kebebe D; Wu Y; Zhang B; Liu Z
    Drug Deliv; 2018 Nov; 25(1):757-765. PubMed ID: 29528244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transferrin-modified nanostructured lipid carriers as multifunctional nanomedicine for codelivery of DNA and doxorubicin.
    Han Y; Zhang Y; Li D; Chen Y; Sun J; Kong F
    Int J Nanomedicine; 2014; 9():4107-16. PubMed ID: 25187713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polyarginine and PEG-AEYLR comodified nanostructured lipid carrier: 10mol% uncleavable PEG-AEYLR showed no shielding effect to polyarginine in vitro while maintaining good tumor targeting in vivo.
    Sun M; Zhu Z; Wang H; Jin S; Yang X; Han C; Pan W
    Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):284-292. PubMed ID: 28355889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined photothermal-chemotherapy of breast cancer by near infrared light responsive hyaluronic acid-decorated nanostructured lipid carriers.
    Zheng S; Nguyen VD; Song SY; Han J; Park JO
    Nanotechnology; 2017 Oct; 28(43):435102. PubMed ID: 28783035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-targeted hyaluronic acid-mPEG modified nanostructured lipid carriers for cantharidin delivery: An in vivo and in vitro study.
    Sun S; Shang E; Ju A; Li Y; Wu Q; Li Q; Yang Y; Guo Y; Yang D; Lv S
    Fitoterapia; 2021 Nov; 155():105033. PubMed ID: 34517057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization.
    Nagaich U; Gulati N
    Drug Deliv Transl Res; 2016 Jun; 6(3):289-98. PubMed ID: 27072979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Orcinol Glucoside Loaded Polymer - Lipid Hybrid Nanostructured Lipid Carriers: Potential Cytotoxic Agents against Gastric, Colon and Hepatoma Carcinoma Cell Lines.
    Nahak P; Gajbhiye RL; Karmakar G; Guha P; Roy B; Besra SE; Bikov AG; Akentiev AV; Noskov BA; Nag K; Jaisankar P; Panda AK
    Pharm Res; 2018 Aug; 35(10):198. PubMed ID: 30151753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Near-infrared mediated quantum dots and paclitaxel co-loaded nanostructured lipid carriers for cancer theragnostic.
    Olerile LD; Liu Y; Zhang B; Wang T; Mu S; Zhang J; Selotlegeng L; Zhang N
    Colloids Surf B Biointerfaces; 2017 Feb; 150():121-130. PubMed ID: 27907859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation.
    Khan S; Baboota S; Ali J; Narang RS; Narang JK
    Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined using of paclitaxel and salinomycin active targeting nanostructured lipid carriers against non-small cell lung cancer and cancer stem cells.
    Zhou J; Sun M; Jin S; Fan L; Zhu W; Sui X; Cao L; Yang C; Han C
    Drug Deliv; 2019 Dec; 26(1):281-289. PubMed ID: 30880491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ursolic acid rich Ocimum sanctum L leaf extract loaded nanostructured lipid carriers ameliorate adjuvant induced arthritis in rats by inhibition of COX-1, COX-2, TNF-α and IL-1: Pharmacological and docking studies.
    Ahmad A; Abuzinadah MF; Alkreathy HM; Banaganapalli B; Mujeeb M
    PLoS One; 2018; 13(3):e0193451. PubMed ID: 29558494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Lipid and Oil Compositions on Physicochemical Properties and Photoprotection of Octyl Methoxycinnamate-loaded Nanostructured Lipid Carriers (NLC).
    Teeranachaideekul V; Morakul B; Boonme P; Pornputtapitak W; Junyaprasert V
    J Oleo Sci; 2020; 69(12):1627-1639. PubMed ID: 33268665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanostructured lipid carriers as novel drug delivery system for lung cancer gene therapy.
    Han Y; Li Y; Zhang P; Sun J; Li X; Sun X; Kong F
    Pharm Dev Technol; 2016; 21(3):277-81. PubMed ID: 25560648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of in vitro and in vivo antitumor effects of gambogic acid-loaded layer-by-layer self-assembled micelles.
    Ke Z; Yang L; Wu H; Li Z; Jia X; Zhang Z
    Int J Pharm; 2018 Jul; 545(1-2):306-317. PubMed ID: 29654896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNA.
    Shao Z; Shao J; Tan B; Guan S; Liu Z; Zhao Z; He F; Zhao J
    Int J Nanomedicine; 2015; 10():1223-33. PubMed ID: 25709444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver-targeted delivery of asiatic acid nanostructured lipid carrier for the treatment of liver fibrosis.
    Zhang YW; Tu LL; Zhang Y; Pan JC; Zheng GL; Yin LN
    Drug Deliv; 2021 Dec; 28(1):2534-2547. PubMed ID: 34854788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lung cancer gene therapy: Transferrin and hyaluronic acid dual ligand-decorated novel lipid carriers for targeted gene delivery.
    Zhang B; Zhang Y; Yu D
    Oncol Rep; 2017 Feb; 37(2):937-944. PubMed ID: 27959442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation, optimization and characteristic of huperzine a loaded nanostructured lipid carriers.
    Yang CR; Zhao XL; Hu HY; Li KX; Sun X; Li L; Chen DW
    Chem Pharm Bull (Tokyo); 2010 May; 58(5):656-61. PubMed ID: 20460792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. L-dopa co-drugs in nanostructured lipid carriers: A comparative study.
    Cortesi R; Esposito E; Drechsler M; Pavoni G; Cacciatore I; Sguizzato M; Di Stefano A
    Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():168-176. PubMed ID: 28024573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.